TrianglePUBLICATIONS · 32401633
Phase I/II Study of CPX-351 Followed by Fludarabine, Cytarabine, and Granulocyte-Colony Stimulating Factor for Children With Relapsed Acute Myeloid Leukemia: A Report From the Children's Oncology Group.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 2020 Jul 1
- First author
- Cooper TM
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Cooper TM
- type
- Author
- name
- Absalon MJ
- type
- Author
- name
- Alonzo TA
- type
- Author
- name
- Gerbing RB
- type
- Author
- name
- Leger KJ
- type
- Author
- name
- Hirsch BA
- type
- Author
- name
- Pollard J
- type
- Author
- name
- Razzouk BI
- type
- Author
- name
- Aplenc R
- type
- Author
- name
- Kolb EA
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Cooper TM
- type
- Author
- name
- Absalon MJ
- type
- Author
- name
- Alonzo TA
- type
- Author
- name
- Gerbing RB
- type
- Author
- name
- Leger KJ
- type
- Author
- name
- Hirsch BA
- type
- Author
- name
- Pollard J
- type
- Author
- name
- Razzouk BI
- type
- Author
- name
- Aplenc R
- type
- Author
- name
- Kolb EA
- type
- Author
- bibliography ids
- nci-bib-2d729653339b58c409279678
- book metadata
- content sha256
- db2cf98d03b3383e3590506e93f3720e83b5ba791e8326b130084a715ba6f2a2
- document type
- citation
- dois
- 10.1200/JCO.19.03306
- electronic publication date
- display
- 2020 May 13
- precision
- day
- year
- 2020
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:32401633
- immutable id
- pubmed:32401633@db2cf98d03b3383e3590506e93f3720e83b5ba791e8326b130084a715ba6f2a2
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- 1527-7755
- issn print
- 0732-183X
- issue
- 19
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 2170-2177
- volume
- 38
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 32401633
- provenance
- batch id
- 40d9eae1f1d369f13109
- provider
- NCBI PubMed ESummary
- record sha256
- 9ce998ef1f4a8d99bbd66a83abbb0567c85728721ee95bd8f459c69701345505
- response sha256
- 03fa1567b6babd78281d8ec4529596b9d4953c2c4ac23257dca371d609645ba9
- retrieved at
- 2026-09-09T23:47:52.637547+00:00
- publication date
- display
- 2020 Jul 1
- precision
- day
- year
- 2020
- publication types
- Clinical Trial, Phase I
- Clinical Trial, Phase II
- Journal Article
- Research Support, N.I.H., Extramural
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Phase I/II Study of CPX-351 Followed by Fludarabine, Cytarabine, and Granulocyte-Colony Stimulating Factor for Children With Relapsed Acute Myeloid Leukemia: A Report From the Children's Oncology Group.
Preserved source evidence · Not medical advice